Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Norepinephrine vs Phenylephrine for Postspinal Hypotension in C-Section
NCT05035888Completed
- Sponsor
- General Hospital of Ningxia Medical University
- Start
- Sep 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of norepinephrine in hypotension (2 arms), sponsored by General Hospital of Ningxia Medical University. Primary endpoints: Effective Dose 50 and Effective Dose 90. Started Sep 2022; status: completed.
02
Drugs
norepinephrine
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT05035888.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05035888.